Closely held Beacon Therapeutics announced the appointment of Dr. Daniel Chung as chief medical officer (CMO), effective immediately. Dr. Chung brings more than three decades of experience in ophthalmology, academic...
Closely held Baylis Medical Technologies announced the appointment of Laura Conquergood as chief executive officer (CEO). Kris Shah, formerly president and CEO, and Frank Baylis, formerly executive chairman, have both...
BioRestorative Therapies (NASDAQ: BRTX) announced the addition of serial regenerative medicine entrepreneur, company builder, and leader, Sandy Lipkins, to focus on technology commercialization and business development...
FibroBiologics (NASDAQ: FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately. Bringing extensive experience in corporate finance, capital markets, and SEC...
Dyadic International (NASDAQ: DYAI) announced that its board of directors has appointed Joe Hazelton as president, effective immediately, as part of an ongoing strategic shift to evolve into a revenue-generating...
enGene Holdings (NASDAQ: ENGN) announced the appointment of Amy Pott as chief global commercialization officer—the company’s first dedicated executive for commercialization endeavors—reporting to Ron Cooper, CEO of...
Closely held CellCentric has announced that it is expanding its leadership team with the appointment of Celia Economides as Chief Financial Officer & Chief Business Officer (CFO & CBO). According...
Laurie Vertuccio has joined Profound Medical (NASDAQ:PROF; TSX:PRN) as Vice President of Global Marketing. The TULSA procedure, performed using Profound’s TULSA-PRO system, has the potential of becoming a mainstream...
Scienture Holdings (NASDAQ: SCNX) announced that Suren Ajjarapu, CEO and chairman of the board, has stepped down. The management team of Dr. Shankar Hariharan and Dr. Narasimhan Mani will assume these roles. Shankar...
Modivcare (NASDAQ:MODV) announced that it has appointed Daniel Silvers to its board of directors (BOD), and board members Craig Barbarosh, David Coulter, and Richard Kerley have resigned, effective April 24, 2025. Mr...